Fmr LLC Raises Holdings in Bath & Body Works, Inc. (NYSE:BBWI)

FMR LLC grew its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 17,496.5% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 2,516,127 shares of the company's stock after buying an additional 2,501,828 shares during the quarter. FMR LLC owned approximately 1.15% of Bath & Body Works worth $80,315,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in BBWI. Loomis Sayles & Co. L P raised its position in shares of Bath & Body Works by 1.2% in the 3rd quarter. Loomis Sayles & Co. L P now owns 312,389 shares of the company's stock worth $9,972,000 after acquiring an additional 3,750 shares in the last quarter. Daiwa Securities Group Inc. increased its stake in shares of Bath & Body Works by 12.6% during the third quarter. Daiwa Securities Group Inc. now owns 26,872 shares of the company's stock valued at $858,000 after purchasing an additional 3,007 shares in the last quarter. Senvest Management LLC purchased a new position in shares of Bath & Body Works during the third quarter valued at approximately $30,537,000. Cerity Partners LLC boosted its position in shares of Bath & Body Works by 227.2% in the 3rd quarter. Cerity Partners LLC now owns 25,093 shares of the company's stock worth $801,000 after purchasing an additional 17,423 shares in the last quarter. Finally, Citigroup Inc. grew its stake in shares of Bath & Body Works by 59.8% in the 3rd quarter. Citigroup Inc. now owns 374,664 shares of the company's stock worth $11,959,000 after buying an additional 140,221 shares during the last quarter. 95.14% of the stock is currently owned by institutional investors.

Bath & Body Works Stock Performance

Shares of BBWI stock traded down $0.18 during mid-day trading on Friday, reaching $36.60. 5,624,271 shares of the company's stock traded hands, compared to its average volume of 4,013,356. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The firm has a 50 day moving average price of $31.72 and a two-hundred day moving average price of $35.24. The firm has a market capitalization of $7.93 billion, a PE ratio of 8.97, a price-to-earnings-growth ratio of 1.38 and a beta of 1.83.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Monday, November 25th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.46 by $0.03. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. The business's revenue for the quarter was up 3.1% compared to the same quarter last year. During the same quarter last year, the company earned $0.48 earnings per share. As a group, equities analysts expect that Bath & Body Works, Inc. will post 3.26 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Shareholders of record on Friday, November 22nd will be given a $0.20 dividend. The ex-dividend date of this dividend is Friday, November 22nd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.19%. Bath & Body Works's payout ratio is currently 19.51%.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, CEO Gina Boswell purchased 6,000 shares of the stock in a transaction that occurred on Wednesday, October 9th. The shares were bought at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now owns 242,987 shares in the company, valued at approximately $7,202,134.68. This trade represents a 2.53 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 0.27% of the company's stock.

Wall Street Analysts Forecast Growth

BBWI has been the topic of a number of recent research reports. Citigroup cut their target price on Bath & Body Works from $48.00 to $35.00 and set a "neutral" rating on the stock in a research note on Tuesday, August 20th. Robert W. Baird cut their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an "outperform" rating on the stock in a report on Thursday, August 29th. Telsey Advisory Group restated an "outperform" rating and issued a $42.00 price objective on shares of Bath & Body Works in a report on Monday, November 25th. TD Cowen increased their target price on Bath & Body Works from $40.00 to $42.00 and gave the company a "buy" rating in a research note on Tuesday, November 26th. Finally, UBS Group decreased their price target on Bath & Body Works from $52.00 to $38.00 and set a "neutral" rating for the company in a research note on Thursday, August 29th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and nine have assigned a buy rating to the stock. According to MarketBeat.com, Bath & Body Works presently has an average rating of "Moderate Buy" and an average target price of $41.88.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.